Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Eidos Therapeutics, Inc. (EIDX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-19Dec-31-18Dec-31-17Dec-31-16
   10-K10-K10-K10-K
Total revenues  26.70.00.00.0
Cost of goods sold  2.50.00.00.0
Gross profit  24.20.00.00.0
            Gross margin  90.6%   
Selling, general and administrative   [+]17.89.22.70.7
Research and development  46.928.59.31.7
EBITDA   [+]-40.4-37.7-12.0 
            EBITDA margin  -151.3%   
Depreciation and amortization  0.10.10.0 
EBIT   [+]-40.5-37.8-12.0-2.4
            EBIT margin  -151.6%   
Interest expense  0.31.0  
Other income (expense), net   [+]2.9-1.90.1-0.2
Pre-tax income  -37.8-40.7-11.9-2.5
Income taxes  0.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%
Net income  -37.8-39.8-11.9-2.5
            Net margin  -141.8%   
   
Basic EPS   [+]($1.03)($1.86)($3.32)($0.98)
Diluted EPS   [+]($1.02)($1.81)($2.76)($0.69)
   
Shares outstanding (basic)   [+]36.621.43.62.6
Shares outstanding (diluted)   [+]37.122.04.33.7
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy